Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR TKIs in non-small-cell lung carcinoma

被引：0
|
作者：
Kim, H. [1 ]
Lee, S. Y. [1 ]
Choi, Y. J. [1 ]
Kim, J. S. [1 ]
Kim, S. T. [1 ]
Park, K. H. [1 ]
Shin, S. W. [1 ]
Kim, Y. H. [1 ]
机构：
[1] Korea Univ, Anam Hosp, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
704
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma
    Kim, Hye Sook
    Sung, Jae Sook
    Yang, Song-Ju
    Kwon, Nak-Jung
    Jin, LiHua
    Kim, Seung Tae
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Han Kyeom
    Kang, Jin-Hyoung
    Kim, Jeong-Oh
    Park, Jae Yong
    Choi, Jin Eun
    Yoon, HyoungKyu
    Park, Chan Kwon
    Yang, Kap-Seok
    Seo, Jeong-Sun
    Kim, Yeul Hong
    PLOS ONE, 2013, 8 (12):
  • [2] Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer
    Yap, Timothy A.
    Popat, Sanjay
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 285 - 295
  • [3] Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer
    Wang, Yuyan
    Duan, Jianchun
    Chen, Hanxiao
    Bai, Hua
    An, Tongtong
    Zhao, Jun
    Wang, Zhijie
    Zhuo, Minglei
    Wang, Shuhang
    Wang, Jie
    ONCOLOGY LETTERS, 2017, 13 (04) : 2425 - 2431
  • [4] Comparison of next-generation sequencing methodologies and direct sequencing for the detection of EGFR mutations in non-small-cell lung carcinoma: Implications for optimal clinical testing.
    Kim, Hye Sook
    Kim, Yeul Hong
    Sung, Jae Sook
    Kim, Seung Tae
    Park, Kyong Hwa
    Kim, Jung Sun
    Choi, Yoon Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer
    Szpechcinski, Adam
    Moes-Sosnowska, Joanna
    Skronska, Paulina
    Lechowicz, Urszula
    Pelc, Magdalena
    Szolkowska, Malgorzata
    Rudzinski, Piotr
    Wojda, Emil
    Maszkowska-Kopij, Krystyna
    Langfort, Renata
    Orlowski, Tadeusz
    Sliwinski, Pawel
    Polaczek, Mateusz
    Chorostowska-Wynimko, Joanna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [6] The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Bai, Hao
    Xiong, Liwen
    Han, Baohui
    ONCOTARGETS AND THERAPY, 2017, 10 : 2335 - 2340
  • [7] The Association between SNP of EGFR and Response to EGFR-TKIs According to EGFR Mutation in Non-Small Cell Lung Cancer
    Jeon, Eun Kyoung
    Shin, Jung-Young
    Cho, Eun Kyung
    Kang, Jin-Hyoung
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S376 - S376
  • [8] Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs
    Lee, Choong-kun
    Kim, Sora
    Lee, Jae Seok
    Lee, Jeong Eun
    Kim, Sung-moo
    Yang, In Seok
    Kim, Hye Ryun
    Lee, Jeong Ho
    Kim, Sangwoo
    Cho, Byoung Chul
    LUNG CANCER, 2017, 113 : 106 - 114
  • [9] Association of allele frequency of EGFR mutation with efficacy of EGFR TKIs in advanced non-small cell lung cancer.
    Li, Xiang-Meng
    Yang, Jin-Ji
    Wu, Long
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
12345